Published in N Engl J Med on August 11, 1988
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 2.62
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet (2003) 2.58
Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med (2009) 2.12
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal (2010) 1.68
Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet (2006) 1.52
Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis Model Mech (2009) 1.49
Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol (2009) 1.47
Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A (1995) 1.43
Treatment and outcome of children with cerebral cavernomas: a survey on 32 patients. Neurol Sci (2009) 1.42
PDCD10 gene mutations in multiple cerebral cavernous malformations. PLoS One (2014) 1.42
CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest (2010) 1.42
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet (2010) 1.39
Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest (2011) 1.36
Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry (1999) 1.29
Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am J Hum Genet (2006) 1.19
Cavernomas of the central nervous system: clinical and neuroimaging manifestations in 47 patients. J Neurol Neurosurg Psychiatry (1991) 1.17
STRIPAK complexes: structure, biological function, and involvement in human diseases. Int J Biochem Cell Biol (2013) 1.13
Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc Natl Acad Sci U S A (2015) 1.09
Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts. Neurogenetics (2007) 0.94
CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics (2013) 0.93
Cystic cavernous angiomas. Neurosurg Rev (2010) 0.93
Pathogenesis of vascular anomalies. Clin Plast Surg (2011) 0.93
Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3). J Biol Chem (2011) 0.93
Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol (2014) 0.91
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet (2014) 0.91
Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q. J Neurol Neurosurg Psychiatry (1997) 0.91
Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate. PLoS One (2010) 0.91
Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med (2012) 0.91
Focal defects in single-celled tubes mutant for Cerebral cavernous malformation 3, GCKIII, or NSF2. Dev Cell (2013) 0.90
Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation. Am J Hum Genet (2002) 0.89
KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med (2015) 0.89
Cavernous malformation of the optic chiasm : case report. J Korean Neurosurg Soc (2008) 0.89
Giant cavernous malformation : a case report and review of the literature. J Korean Neurosurg Soc (2008) 0.87
Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations. Neurosurg Rev (2013) 0.83
Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab (2015) 0.82
Update on the molecular genetics of vascular anomalies. Lymphat Res Biol (2005) 0.82
Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management. Eur J Hum Genet (2011) 0.82
Small deletion at the 7q21.2 locus in a CCM family detected by real-time quantitative PCR. J Biomed Biotechnol (2010) 0.82
The value of susceptibility weighted magnetic resonance imaging in evaluation of patients with familial cerebral cavernous angioma. Int J Clin Exp Med (2014) 0.82
Identification of two novel mutations and of a novel critical region in the KRIT1 gene. Neurogenetics (2006) 0.81
Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients. Childs Nerv Syst (2006) 0.80
Radiological features of childhood giant cavernous malformations. Neuroradiology (2010) 0.79
Intramedullary spinal cord cavernous malformations: report of ten new cases. Neurosurg Rev (2004) 0.79
Inherited cavernous malformations of the central nervous system: clinical and genetic features in 19 Swiss families. Neurosurg Rev (2009) 0.79
Cavernous malformations associated with dural arteriovenous shunts in the central nervous system. Neuroradiology (2012) 0.79
Torturing a blood vessel. Nat Med (2009) 0.79
Intramedullary cavernous angioma of the spinal cord in a pediatric patient, with multiple cavernomas, familial occurrence and partial spontaneous regression: case report and review of the literature. Childs Nerv Syst (2007) 0.78
Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form. Neuroradiol J (2016) 0.78
The cerebral cavernous malformation 3 gene is necessary for senescence induction. Aging Cell (2015) 0.77
Two-hit mechanism in cerebral cavernous malformation? A case of monozygotic twins with a CCM1/KRIT1 germline mutation. Neurosurg Rev (2013) 0.77
Familial cerebral cavernous malformation: report of a further Italian family. Neurol Sci (2009) 0.76
Management of intracranial cavernous malformation in pediatric patients. Childs Nerv Syst (2007) 0.76
Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients. Biomed Res Int (2013) 0.76
Introduction to cerebral cavernous malformation: a brief review. BMB Rep (2016) 0.76
Systems biology and proteomic analysis of cerebral cavernous malformation. Expert Rev Proteomics (2014) 0.76
A novel CCM1 mutation associated with multiple cerebral and vertebral cavernous malformations. BMC Neurol (2014) 0.76
Genetics of cerebral cavernous malformations: current status and future prospects. J Neurosurg Sci (2015) 0.76
Familial cavernous angiomas masquerading as multiple sclerosis. Postgrad Med J (1998) 0.75
Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus. J Biol Chem (2016) 0.75
Post-irradiation lumbosacral radiculopathy associated with multiple cavernous malformations of the cauda equina: Case report and review of the literature. Surg Neurol Int (2017) 0.75
Multiple cavernous malformations presenting in a patient with Poland syndrome: A case report. J Med Case Rep (2011) 0.75
Cerebral Cavernous Malformation: A Portuguese Family with a Novel CCM1 Mutation. Case Rep Neurol (2016) 0.75
Co-occurrence of a cerebral cavernous malformation and an orbital cavernous hemangioma in a patient with seizures and visual symptoms: Rare crossroads for vascular malformations. Surg Neurol Int (2014) 0.75
The value of T(2) (*)-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families. Exp Ther Med (2012) 0.75
Vascular malformations of central nervous system: A series from tertiary care hospital in South India. J Neurosci Rural Pract (2016) 0.75
Pediatric cerebral cavernous malformations: Genetics, pathogenesis, and management. Surg Neurol Int (2016) 0.75
KRIT1 mutations in three Japanese pedigrees with hereditary cavernous malformation. Hum Genome Var (2016) 0.75
A Novel CCM2 Gene Mutation Associated with Familial Cerebral Cavernous Malformation. Front Aging Neurosci (2016) 0.75
Symptomatic spinal cavernous malformations: indication for microsurgical treatment and outcome. Eur Spine J (2011) 0.75
The pathobiology of vascular malformations: insights from human and model organism genetics. J Pathol (2016) 0.75
Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysis. Mol Biosyst (2014) 0.75
Cavernous malformation of the optic chiasm: Neuro-endoscopic removal. Asian J Neurosurg (2016) 0.75
Clinical Management of Cavernous Malformations. Curr Cardiol Rep (2017) 0.75
Intramedullary spinal arteriovenous malformation in a boy of familial cerebral cavernous hemangioma. Childs Nerv Syst (2007) 0.75
Cavernous malformations of central nervous system in pediatric patients: our single-centered experience in 50 patients and review of literature. Childs Nerv Syst (2017) 0.75
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia. Childs Nerv Syst (2015) 0.75
Concepts and hypothesis: integrin cytoplasmic domain-associated protein-1 (ICAP-1) as a potential player in cerebral cavernous malformation. J Neurol (2012) 0.75
A proposed grading system for arteriovenous malformations. J Neurosurg (1986) 6.38
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer (1997) 3.58
Neurologic complications of cerebral angiography. AJNR Am J Neuroradiol (1994) 3.14
Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12
The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg (1994) 3.06
A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis (1985) 2.94
Civilian gunshot wounds to the head: a prospective study. Neurosurgery (1990) 2.77
De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literature. J Neurosurg (1997) 2.72
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis (1986) 2.32
Late angiographic follow-up review of surgically treated aneurysms. J Neurosurg (1999) 2.23
Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol (1998) 2.21
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14
Impact of traumatic subarachnoid hemorrhage on outcome in nonpenetrating head injury. Part II: Relationship to clinical course and outcome variables during acute hospitalization. J Trauma (1996) 2.13
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann Intern Med (1987) 2.05
Acute axis fractures. Analysis of management and outcome in 340 consecutive cases. Spine (Phila Pa 1976) (1997) 2.04
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97
Facial neuromuscular retraining for oral synkinesis. Plast Reconstr Surg (1997) 1.97
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke (1987) 1.96
Efficacy of MR vs CT in epilepsy. AJR Am J Roentgenol (1989) 1.94
The MRI appearance of cavernous malformations (angiomas). J Neurosurg (1987) 1.93
Axis fractures: a comprehensive review of management and treatment in 107 cases. Neurosurgery (1985) 1.91
Normal perfusion pressure breakthrough theory. Clin Neurosurg (1978) 1.87
Autoregulation of blood flow. Circ Res (1986) 1.84
Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control (1995) 1.83
Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infect Immun (1985) 1.80
Characteristics and surgical treatment of dolichoectatic and fusiform aneurysms. J Neurosurg (1996) 1.79
Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg (1997) 1.75
A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet (1995) 1.74
Repair of vertebral artery injury during anterior cervical decompression. Spine (Phila Pa 1976) (1994) 1.73
Magnetic resonance image of postcraniotomy retained cotton or rayon. Case illustration. J Neurosurg (1998) 1.70
The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol (1997) 1.69
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke (1987) 1.66
Effect of erythrocyte aggregation on velocity profiles in venules. Am J Physiol Heart Circ Physiol (2001) 1.66
Changes in facial movement after maxillary osteotomies. J Oral Maxillofac Surg (1997) 1.66
Combined medical and surgical treatment after acute spinal cord injury: results of a prospective pilot study to assess the merits of aggressive medical resuscitation and blood pressure management. J Neurosurg (1997) 1.64
Congenital tethered spinal cord syndrome in adults. J Neurosurg (1998) 1.61
Hypothermic circulatory arrest in neurovascular surgery: evolving indications and predictors of patient outcome. Neurosurgery (1998) 1.57
The interspinous method of posterior atlantoaxial arthrodesis. J Neurosurg (1991) 1.56
The relation between production of cytotoxin and clinical features in shigellosis. J Infect Dis (1986) 1.54
Clinical use of a frameless stereotactic arm: results of 325 cases. J Neurosurg (1995) 1.54
Patients with spinal cord cavernous malformations are at an increased risk for multiple neuraxis cavernous malformations. Neurosurgery (1999) 1.53
Anterior cervical interbody fusion using autogeneic and allogeneic bone graft substrate: a prospective comparative analysis. J Neurosurg (1996) 1.53
Choroid plexus carcinoma in siblings: a study by light and electron microscopy with Ki-67 immunocytochemistry. J Neuropathol Exp Neurol (1989) 1.52
Animal model for cerebral arteriovenous malformation. Acta Neurochir (Wien) (2000) 1.51
Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology (1986) 1.50
Measurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2. J Biol Chem (1985) 1.49
Erythrocyte velocity measurement in microvessels by a two-slit photometric method. J Appl Physiol (1967) 1.49
The prospective application of a grading system for arteriovenous malformations. Neurosurgery (1994) 1.48
The transoral approach to the superior cervical spine. A review of 53 cases of extradural cervicomedullary compression. J Neurosurg (1989) 1.48
False aneurysm associated with rupture of an arteriovenous malformation--implications for treatment: case report. Neurosurgery (1993) 1.47
Aneurysms of the basilar artery treated with circulatory arrest, hypothermia, and barbiturate cerebral protection. J Neurosurg (1988) 1.47
Detection of delayed cerebral vasospasm, after rupture of intracranial aneurysms, by magnetic resonance angiography. Neurosurgery (1997) 1.46
Microvascular and tissue oxygen gradients in the rat mesentery. Proc Natl Acad Sci U S A (1998) 1.46
Cavernous malformations of the brain stem. A review of 139 cases. Acta Neurochir (Wien) (1994) 1.46
Blister or berry aneurysm. J Neurosurg (1999) 1.45
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol (1975) 1.44
Surgical decisions on the basis of magnetic resonance angiography of the carotid arteries. Neurosurgery (1993) 1.43
Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest (1989) 1.42
Viral shedding and fecal IgA response after Norwalk virus infection. J Infect Dis (1995) 1.41
Cavernous malformations of the brainstem: experience with 100 patients. J Neurosurg (1999) 1.41
A longitudinal study of patients with venous malformations: documentation of a negligible hemorrhage risk and benign natural history. Neurology (1998) 1.41
Red blood cell mass and plasma volume changes in manned space flight. JAMA (1967) 1.41
Magnetic resonance imaging of the transverse atlantal ligament for the evaluation of atlantoaxial instability. J Neurosurg (1991) 1.40
Improved transdural exposure and temporary occlusion of the petrous internal carotid artery for cavernous sinus surgery. Technical note. J Neurosurg (1993) 1.40
Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg (1990) 1.40
Norwalk virus antigen and antibody response in an adult volunteer study. J Clin Microbiol (1987) 1.39
Gliomas: classification with MR imaging. Radiology (1990) 1.39
Cross-facial nerve grafting for facial reanimation: effect on normal hemiface motion. J Reconstr Microsurg (1996) 1.39
Evaluation and treatment of the plastic surgical patient having a potential to bleed. Plast Reconstr Surg (1995) 1.38
Revascularization and aneurysm surgery: current techniques, indications, and outcome. Neurosurgery (1996) 1.38
Orbitozygomatic craniotomy. Technical note. J Neurosurg (1998) 1.37
Pathogenesis of diabetic neuropathy. Ann Neurol (1986) 1.36
Giant serpentine aneurysms: a review and presentation of five cases. AJNR Am J Neuroradiol (1995) 1.36
Regional ventilation and perfusion after lung transplantation in patients with emphysema. N Engl J Med (1970) 1.35
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry (1997) 1.34
Management of recurrent CSF rhinorrhea of the middle and posterior fossa. J Neurosurg (1978) 1.33
Regulation of blood flow in single capillaries. Am J Physiol (1967) 1.31
Disappearance and reappearance of cerebral aneurysm in serial arteriograms. Case report. J Neurosurg (1974) 1.30
Diagnosis of sacral perineural cysts by nuclear magnetic resonance. Surg Neurol (1984) 1.29
Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery (1991) 1.28
Rheological effects of red blood cell aggregation in the venous network: a review of recent studies. Biorheology (2001) 1.28
A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol (1995) 1.28
Microvascular and tissue oxygen distribution. Cardiovasc Res (1996) 1.27
Suppression of insulin release by fish-insulin-induced hypoglycaemia: with reference to the diagnosis of insulinomas. Lancet (1973) 1.27
Genesis of a dural arteriovenous malformation in a rat model. J Neurosurg (1995) 1.26
Late complications of carotid ligation in the treatment of intracranial aneurysms. J Neurosurg (1981) 1.26
Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother (2001) 1.24